congrats-4

Pre-Qualified

It seems that you are pre-qualified for an off-label metabolic syndrome program that repurposes a recently approved drug by the U.S. Food and Drug Administration for the treatment of obesity – Zepbound (tirzepatide).

This new drug targets adults with obesity or overweight with at least one weight-related comorbidity, for use in addition to a reduced calorie diet and increased physical activity.